Engineering neural tissue using pluripotent stem cells

使用多能干细胞改造神经组织

• 批准号: RGPIN-2017-04044
• 负责人: Willerth, Stephanie
• 金额: $ 1.75万
• 依托单位: University of Victoria
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=709959
• 关键词: Engineering; neural; tissue; using; pluripotent

Different kind of cells make up the brain and spinal cord. Replicating these complex structures provides us with a significant opportunity to discover how such tissues form in the body. Such engineered neural tissues can be used for applications in pharmacological screening instead of donated human tissues. One popular strategy for tissue engineering uses biomaterial scaffolds to deliver signals that promote stem cells to differentiate into neural tissue. My group works with human induced pluripotent stem cells (hiPSCs), adult cells reprogrammed into a state where they can become any type of cell found in an organism. This property makes them an excellent cell source for tissue engineering. My group identified a number of chemical and physical cues that drive the differentiation of hiPSCs into neural tissue, which serves as a starting point for this research program. However, current methods for engineering neural tissue using hiPSCs require lengthy, labor intensive protocols. The overarching goal of this research program is to engineer functional neural tissues from hiPSCs by developing bioactive scaffolds that present the necessary chemical and physical cues for promoting rapid differentiation that can be translated into bioprinting applications. This research program consists of two different aims for achieving this goal, and the results of this research program will be used to generate neural tissue in a rapid and high throughput manner compared to current methods. The first aim investigates how to modify the properties of 3D fibrin scaffolds so that they can generate functional neural tissue from hiPSCs. We can manipulate the mechanical properties of these scaffolds using cross-linking agents to increase their stability. We also can enhance their chemical properties by functionalizing them with bioactive cues like peptides that promote neuronal differentiation of hiPSCs. We will then determine the influence of these two types of cues on hiPSC differentiation by using these scaffolds as bioink for 3D printing of functional neural tissues. The second aim will elucidate how the controlled release of novel chemical cues from microspheres can rapidly differentiate hiPSCs into neurons. These chemical cues include the transcription factor Ascl1 (shown to efficiently produce neurons) functionalized with intracellular protein delivery technology, purmorphamine (shown to enhance motor neuron differentiation), and guggulsterone (shown to enhance dopaminergic neuron differentiation). Currently, no existing drug delivery systems can generate controlled release of these molecules all of which promote rapid differentiation of hiPSCs into neural tissue. We will demonstrate how different combinations and concentrations of these drug-releasing microspheres can be used to engineer two different types of neural tissue, which could then be used for drug screening applications.

不同种类的细胞组成了大脑和脊髓。复制这些复杂的结构为我们提供了一个重要的机会，以发现这些组织如何在体内形成。这种工程化的神经组织可以用于药理学筛选中的应用，而不是捐赠的人体组织。一种流行的组织工程策略是使用生物材料支架来传递信号，促进干细胞分化为神经组织。我的团队研究人类诱导多能干细胞（hiPSC），成年细胞重新编程成一种状态，它们可以成为生物体中发现的任何类型的细胞。这种特性使它们成为组织工程的优秀细胞来源。我的团队确定了许多化学和物理线索，这些线索推动hiPSC分化为神经组织，这是本研究项目的起点。然而，目前使用hiPSC工程化神经组织的方法需要冗长的劳动密集型方案。这项研究计划的总体目标是通过开发生物活性支架来从hiPSC中工程化功能性神经组织，这些支架提供了促进快速分化的必要化学和物理线索，可以转化为生物打印应用。该研究计划包括两个不同的目标，以实现这一目标，该研究计划的结果将用于以快速和高通量的方式生成神经组织相比，目前的方法。 第一个目的是研究如何修改3D纤维蛋白支架的特性，使其能够从hiPSC中生成功能性神经组织。我们可以使用交联剂来操纵这些支架的机械性能，以增加其稳定性。我们还可以通过用生物活性因子（如促进hiPSC神经元分化的肽）使它们功能化来增强它们的化学性质。然后，我们将通过使用这些支架作为功能性神经组织3D打印的生物墨水来确定这两种类型的线索对hiPSC分化的影响。 第二个目标将阐明从微球中控制释放新型化学信号如何使hiPSC快速分化为神经元。这些化学信号包括用细胞内蛋白质递送技术功能化的转录因子Ascl 1（显示出有效地产生神经元）、purmorphamine（显示出增强运动神经元分化）和guggulsterone（显示出增强多巴胺能神经元分化）。目前，没有现有的药物递送系统可以产生这些分子的受控释放，所有这些分子都促进hiPSC快速分化成神经组织。我们将展示这些药物释放微球的不同组合和浓度如何用于工程两种不同类型的神经组织，然后可用于药物筛选应用。